Glucagon-like peptide-1: modulator of β-cell dysfunction and death.
about
The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic CancerObesity associated with type 2 diabetes mellitus is linked to decreased PC1/3 mRNA expression in the Jejunum.Identification of Human Islet Amyloid Polypeptide as a BACE2 Substrate.DPP-4 inhibitors: focus on safety.TLR ligands and butyrate increase Pyy expression through two distinct but inter-regulated pathways.Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes.Neuroprotective Activity of Sitagliptin via Reduction of Neuroinflammation beyond the Incretin Effect: Focus on Alzheimer's Disease
P2860
Q26738873-B2A07400-6BBD-41B2-8E0D-6DBA01D245ACQ35169210-8E03C2A7-8FB6-4640-AEF7-78D124ABF3F3Q35913113-63D834D5-4B82-4FED-907E-31017E146B73Q38285608-EDD46C1B-9C01-4879-8AD0-64C4AD9EC4E1Q38758563-EF8370E2-A43F-43FA-AE22-1BA5A3ED0EA9Q55195472-76982903-FE74-4C19-A956-C6CFFE69AA04Q58773068-F614B953-5256-4774-8D25-EF9D63DEA813
P2860
Glucagon-like peptide-1: modulator of β-cell dysfunction and death.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Glucagon-like peptide-1: modulator of β-cell dysfunction and death.
@en
type
label
Glucagon-like peptide-1: modulator of β-cell dysfunction and death.
@en
prefLabel
Glucagon-like peptide-1: modulator of β-cell dysfunction and death.
@en
P2093
P2860
P356
P1476
Glucagon-like peptide-1: modulator of β-cell dysfunction and death.
@en
P2093
P2860
P304
P356
10.1111/DOM.12165
P478
15 Suppl 3
P577
2013-09-01T00:00:00Z